Growth of primary human acute leukemia in severe combined immunodeficient mice.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 1893976)

Published in Exp Hematol on October 01, 1991

Authors

C De Lord1, R Clutterbuck, J Titley, M Ormerod, T Gordon-Smith, J Millar, R Powles

Author Affiliations

1: Section of Medicine, Institute of Cancer Research, Surrey, UK.

Articles by these authors

(truncated to the top 100)

International uniform response criteria for multiple myeloma. Leukemia (2006) 17.78

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia (2008) 3.41

Intra-aneurysmal thrombosis as a possible cause of delayed aneurysm rupture after flow-diversion treatment. AJNR Am J Neuroradiol (2010) 3.03

Prostate cancer in Victoria in 1993: patterns of reported management. Med J Aust (2000) 2.00

Part-time women general practitioners--workload and remuneration. J R Coll Gen Pract (1989) 1.92

Selective cardiac sympathetic blockade as an adjunct to bronchodilator therapy. Thorax (1969) 1.89

Consequences and treatment of ovarian failure after total body irradiation for leukaemia. BMJ (1989) 1.84

Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet (2001) 1.76

Clonal characterization of mouse mammary luminal epithelial and myoepithelial cells separated by fluorescence-activated cell sorting. In Vitro Cell Dev Biol Anim (1998) 1.74

A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia. Nature (1987) 1.56

Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia? Bone Marrow Transplant (2002) 1.49

Peripheral blood stem cell transplantation may result in increased relapse of acute myeloid leukaemia due to reinfusion of a higher number of malignant cells. Bone Marrow Transplant (1995) 1.45

Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma. Cancer (2000) 1.45

Myeloma and benign intracranial hypertension. BMJ (1992) 1.41

Electrochemical, pharmacological and electrophysiological evidence of rapid dopamine release and removal in the rat caudate nucleus following electrical stimulation of the median forebrain bundle. Eur J Pharmacol (1985) 1.39

Differentiation of separated mouse mammary luminal epithelial and myoepithelial cells cultured on EHS matrix analyzed by indirect immunofluorescence of cytoskeletal antigens. J Histochem Cytochem (1999) 1.39

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100). Leukemia (2009) 1.38

Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres. Br J Haematol (2001) 1.36

Carbon fibre microelectrodes. J Neurosci Methods (1979) 1.34

An immunomagnetic separation method using superparamagnetic (MACS) beads for large-scale purification of human mammary luminal and myoepithelial cells. Epithelial Cell Biol (1994) 1.34

The immediate shift of afferent drive to dorsal column nucleus cells following deafferentation: a comparison of acute and chronic deafferentation in gracile nucleus and spinal cord. Exp Neurol (1976) 1.34

Rapid virological surveillance of community influenza infection in general practice. BMJ (2000) 1.31

Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology (1993) 1.31

T cell regeneration after allogeneic bone marrow transplantation. Clin Exp Immunol (1983) 1.24

CEA, ZGM and EMA localization in cells of pleural and peritoneal effusion: a preliminary study. Invest Cell Pathol (1981) 1.22

Consensus conference on European preparedness for haematological and other medical management of mass radiation accidents. Ann Hematol (2006) 1.21

Immunotherapy for acute myelogenous leukaemia. Br J Cancer Suppl (1973) 1.20

Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma. Ann Oncol (2008) 1.18

Accuracy and value of the Hemoccult test in symptomatic patients. Br Med J (Clin Res Ed) (1983) 1.17

Can spontaneous spinal epidural haematoma be managed safely without operation? A report of four cases. J Neurol Neurosurg Psychiatry (2000) 1.15

Method of removing abnormal protein rapidly from patients with malignant paraproteinaemias. Br Med J (1971) 1.14

High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. J Clin Oncol (1994) 1.11

Specific autostimulating factor released by lymphocytes. Nature (1971) 1.11

A trial of fluphenazine enanthate in chronic schizophrenia. Br J Psychiatry (1967) 1.09

Test for cryopreservation efficiency of human acute myelogenous leukaemia cells relevant to clinical requirements. Cryobiology (1977) 1.06

Striatal dopamine uptake in the rat: in vivo analysis by fast cyclic voltammetry. Neurosci Lett (1984) 1.06

Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse. Leuk Lymphoma (1999) 1.05

Joint afferent fibres responding to muscle stretch, vibration and contraction. Brain Res (1973) 1.05

The role of autologous transplantation in patients with multiple myeloma aged 65 years and over. Bone Marrow Transplant (2000) 1.04

Quantification of noradrenaline iontophoresis. Nature (1980) 1.00

A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up results. Br J Haematol (1998) 0.99

Flexion-extension sensitivity of elbow joint afferents in cat. Exp Brain Res (1975) 0.98

Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-up. Bone Marrow Transplant (2000) 0.98

Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet (2000) 0.97

Accounting for medical variation: the case of prescribing activity in a New Zealand general practice sample. Soc Sci Med (1994) 0.97

Concentration-dependent actions of stimulated dopamine release on neuronal activity in rat striatum. Neuroscience (1990) 0.96

Monitoring exocytosis from single mast cells by fast voltammetry. Pflugers Arch (1991) 0.96

Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. Blood (2000) 0.95

Inhibition of bombesin-induced mitogenesis by pertussis toxin: dissociation from phospholipase C pathway. Biochem Biophys Res Commun (1987) 0.95

Simultaneous "real-time" electrochemical and electrophysiological recording in brain slices with a single carbon-fibre microelectrode. J Neurosci Methods (1993) 0.95

Presynaptic regulation of dopamine release in corpus striatum monitored in vitro in real time by fast cyclic voltammetry. Brain Res (1990) 0.95

Bone marrow transplantation for primary refractory acute leukaemia. Bone Marrow Transplant (1994) 0.94

Application of fast cyclic voltammetry to measurement of electrically evoked dopamine overflow from brain slices in vitro. J Neurosci Methods (1990) 0.94

Stimulated limbic and striatal dopamine release measured by fast cyclic voltammetry: anatomical, electrochemical and pharmacological characterisation. Brain Res (1988) 0.94

Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosis. Br J Cancer (1999) 0.94

The histological diagnosis of cutaneous graft versus host disease: relationship of skin changes to marrow purging and other clinical variables. Histopathology (1987) 0.93

Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma. Bone Marrow Transplant (2002) 0.93

Very long-term amnesia in association with temporal lobe epilepsy: evidence for multiple-stage consolidation processes. Brain Cogn (1997) 0.93

Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor. Cancer Res (1994) 0.93

Striatal dopamine terminals release serotonin after 5-HTP pretreatment: in vivo voltammetric data. Brain Res (1990) 0.93

Restructuring of the somatotopic map and appearance of abnormal neuronal activity in the gracile nucleus after partial deafferentation. Exp Neurol (1976) 0.93

Diffusion and uptake of dopamine in rat caudate and nucleus accumbens compared using fast cyclic voltammetry. Brain Res (1988) 0.93

Patterns of maturation in short-term culture of human acute myeloid leukaemic cells. Br J Cancer (1979) 0.92

Ectoenzyme regulation by phenotypically distinct fibroblast sub-populations isolated from the human mammary gland. J Cell Sci (1994) 0.92

Quantitative ionophoresis of catecholamines using multibarrel carbon fibre microelectrodes. J Neurosci Methods (1981) 0.92

'GAP' in radiotherapy services in Australia and New Zealand in 2009. J Med Imaging Radiat Oncol (2010) 0.91

A comparison between the in vivo and in vitro activity of five potent and competitive NMDA antagonists. Br J Pharmacol (1988) 0.91

Convergence of joint, cutaneous and muscle afferents onto cuneate neurones in the cat. Brain Res (1979) 0.91

Regional differences in extracellular ascorbic acid levels in the rat brain determined by high speed cyclic voltammetry. Brain Res (1984) 0.91

A method for etching the tips of carbon fibre microelectrodes. J Neurosci Methods (1980) 0.91

The Victorian Lung Cancer Registry pilot: improving the quality of lung cancer care through the use of a disease quality registry. Lung (2014) 0.91

Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria. Bone Marrow Transplant (2001) 0.91

Physician supply in Canada: how much is enough? Hosp Q (2001) 0.90

Mutational activation of the N-ras oncogene assessed in primary clonogenic culture of acute myeloid leukemia (AML): implications for the role of N-ras mutation in AML pathogenesis. Blood (1992) 0.90

Measurement of the concentration of 5-hydroxytryptamine ejected during iontophoresis using multibarrel carbon fibre microelectrodes. Life Sci (1980) 0.90

Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA-typing. Br J Haematol (1993) 0.89

Letter: Cause of early death in acute leukaemia. Lancet (1976) 0.89

Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands. J Pharmacol Exp Ther (1989) 0.89

Comparison of thymidylate synthase (TS) protein up-regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues. Clin Cancer Res (2000) 0.89

Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data. Br J Pharmacol (1991) 0.89

Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission. Bone Marrow Transplant (1996) 0.89

Programmed cell death in response to chemotherapeutic agents in human germ cell tumour lines. Eur J Cancer (1995) 0.88

HLA-DR expression in epidermal keratinocytes after allogeneic bone marrow transplantation. Relationship to histology, rash, marrow purging, and systemic graft-versus-host disease. Transplantation (1988) 0.88

Paradoxical emboli after central venous catheter removal. Ann Oncol (2000) 0.88

A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold? Bone Marrow Transplant (2000) 0.88

Signal intensity on MRI of basal ganglia in multiple sclerosis. J Neurol Neurosurg Psychiatry (1995) 0.88

Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies. Bone Marrow Transplant (1997) 0.87

Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma. Br J Cancer (2000) 0.87

Spontaneous regression of human acute myeloid leukaemia xenografts and phenotypic evidence for maturation. Br J Cancer (1979) 0.86

DNA ploidy in early gastric carcinoma (T1): a flow cytometric study of 100 European cases. Gut (1993) 0.86

Early identification of patients at risk of death due to infections, hemorrhage, or graft failure after allogeneic bone marrow transplantation on the basis of the leukocyte counts. Bone Marrow Transplant (1997) 0.86

Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study. Br J Pharmacol (1988) 0.85

In vivo voltammetric characterization of low affinity striatal dopamine uptake: drug inhibition profile and relation to dopaminergic innervation density. Brain Res (1986) 0.85

A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C-VAMP) as induction treatment followed by autografting in previously untreated myeloma. Br J Haematol (1997) 0.85

Fibre size distribution in the elbow joint nerve of the cat. J Anat (1980) 0.85

Dangerous advances in measurements from digital subtraction angiography: when is a millimeter not a millimeter? AJNR Am J Neuroradiol (2008) 0.84

Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in women. Bone Marrow Transplant (1996) 0.84

Delayed engraftment associated with splenomegaly in patients undergoing bone marrow transplantation for chronic myeloid leukaemia. Bone Marrow Transplant (1990) 0.84

An unusual presentation of acute myeloid leukaemia with pericardial and pleural effusions due to granulocytic sarcoma. Leuk Lymphoma (1993) 0.84

Dissociation of the actions of uptake blockers upon dopamine overflow and uptake in the rat nucleus accumbens: in vivo voltammetric data. Neuropharmacology (1989) 0.84